Page last updated: 2024-12-06

glycyl-glycyl-glycyl-glycine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Glycyl-glycyl-glycyl-glycine, also known as tetra-glycine, is a tetrapeptide composed of four glycine amino acids linked together. It is a relatively simple peptide that has been studied for its potential applications in various fields, including medicine, materials science, and food chemistry.

Synthesis: Tetra-glycine can be synthesized through various methods, including solid-phase peptide synthesis, which involves the stepwise addition of amino acids to a growing peptide chain attached to a solid support.

Effects: Tetra-glycine exhibits several interesting biological effects. It has been shown to have antioxidant properties and can protect against oxidative stress. Additionally, it has been investigated as a potential therapeutic agent for conditions such as Alzheimer's disease and Parkinson's disease.

Importance: The study of tetra-glycine is important due to its potential applications in various fields:

* Medicine: Tetra-glycine's antioxidant and neuroprotective properties make it a promising candidate for developing new drugs for neurodegenerative diseases.
* Materials science: Tetra-glycine can be used as a building block for creating self-assembling peptide nanomaterials, which have applications in areas like drug delivery, tissue engineering, and bioelectronics.
* Food chemistry: Tetra-glycine has been studied for its potential use as a food additive to improve the flavor and texture of certain products.

Why it is studied: The simple structure and readily available synthetic routes make tetra-glycine an attractive model system for studying the properties and functions of peptides. Its potential applications in various fields continue to drive research interest in this compound.'

Cross-References

ID SourceID
PubMed CID69481
CHEMBL ID378905
SCHEMBL ID93766
MeSH IDM0134153

Synonyms (40)

Synonym
nsc-89178
637-84-3
nsc89178
glycine, n-[n-(n-glycylglycyl)glycyl]-
glycylglycylglycylglycine
glycyl-glycyl-glycyl-glycine
gly-gly-gly-gly
NCIOPEN2_005522
tetraglycine
2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetic acid
CHEMBL378905
h-gly-gly-gly-gly-oh
G0127
AKOS009159037
unii-t171gru26b
t171gru26b ,
n-(n-(n-glycylglycyl)glycyl)glycine
nsc 89178
einecs 211-303-4
FT-0632710
SCHEMBL93766
([(([(aminoacetyl)amino]acetyl)amino)acetyl]amino)acetic acid #
DTXSID50213103
glycine, n-(n-(n-glycylglycyl)glycyl)-
(triglycyl)glycine
glycine tetrapeptide
glycine, glycylglycylglycyl-
gly4
mfcd00008129
glycyl-glycyl-glycyl-glycine (h-gly-gly-gly-gly-oh)
CS-0204513
2-(2-(2-(2-aminoacetamido)acetamido)acetamido)acetic acid
Q27289539
A852237
T72755
tetraglycine; glycylglycylglycylglycine; glycyl-glycyl-glycyl-glycine; gly-gly-gly-gly
2-(2-(2-(2-aminoacetamido)acetamido)acetamido)aceticacid
BS-23865
HY-W142467
2-{2-[2-(2-aminoacetamido)acetamido]acetamido}acetic acid

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In vitro toxicity studies demonstrated that the hyaluronic acid derivative was much less toxic than the corresponding PNVA- co-AA derivatives, and that both the polymers and their metabolites did not exhibit genotoxicity."( Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
Baba, M; Sakuma, S; Shigeno, K; Tanishita, S; Tobita, E; Tomono, T; Ukawa, M; Uto, T; Yagi, H; Yoshida, Y, 2019
)
0.51

Bioavailability

ExcerptReferenceRelevance
"Our previous mouse studies demonstrated that mean bioavailability of exendin-4, which is an injectable glucagon-like peptide-1 (GLP-1) analogue whose molecular weight (Mw) and isoelectric point (pI) are ca."( Nasal absorption enhancement of protein drugs independent to their chemical properties in the presence of hyaluronic acid modified with tetraglycine-L-octaarginine.
Igi, R; Ishizaki, S; Kobayashi, H; Kumagai, H; Miwa, T; Miyata, K; Nonomura, M; Sakuma, S; Tobita, E; Tomono, T; Ukawa, M; Yagi, H, 2020
)
0.56
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (10)

Assay IDTitleYearJournalArticle
AID781326pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X2014Pharmaceutical research, Apr, Volume: 31, Issue:4
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
AID266247Activation of human PEPT1 expressed in MDCK cells relative to Gly-Sar2006Journal of medicinal chemistry, Jun-15, Volume: 49, Issue:12
Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
AID266249Binding affinity to human PEPT1 assessed as inhibition of [14C]Gly-Sar uptake in MDCK cells2006Journal of medicinal chemistry, Jun-15, Volume: 49, Issue:12
Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
AID388081Antifungal activity at Candida albicans2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID388086Antibacterial activity at Escherichia coli2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID680762TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.004 uM, Gly4: 5000 uM) in Xenopus laevis oocytes2003The Journal of pharmacy and pharmacology, Jul, Volume: 55, Issue:7
Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin.
AID682118TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.004 uM, Gly5: 5000 uM) in Xenopus laevis oocytes2003The Journal of pharmacy and pharmacology, Jul, Volume: 55, Issue:7
Contribution of organic anion transporting polypeptide OATP-C to hepatic elimination of the opioid pentapeptide analogue [D-Ala2, D-Leu5]-enkephalin.
AID388088Antifungal activity at Candida albicans assessed as concentration required to lower the MIC of fluconazole from 32 to 1 ug/mL after 48 hrs2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
AID266246Activation of human PEPT1 expressed in MDCK cells2006Journal of medicinal chemistry, Jun-15, Volume: 49, Issue:12
Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
AID388089Antibacterial activity at Escherichia coli assessed as concentration required to lower the MIC of erythromycin from 64 to 1 ug/mL after 24 hrs2008Bioorganic & medicinal chemistry letters, Oct-15, Volume: 18, Issue:20
Synthesis of chimeric tetrapeptide-linked cholic acid derivatives: impending synergistic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (10.34)18.7374
1990's2 (6.90)18.2507
2000's12 (41.38)29.6817
2010's10 (34.48)24.3611
2020's2 (6.90)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 22.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index22.45 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (22.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]